Representative image.

The Ramco Cements on Monday reported 51.1 per cent rise in consolidated net profit at Rs 215.92 crore for the fourth quarter ended March 31, 2021 helped by growth in sales. It had posted a net profit of Rs 142.90 crore in January-March 2019-20, the Ramco Cements said in a regulatory filing.

Total revenue was up 16.93 per cent to Rs 1,641.53 crore during the quarter under review as against Rs 1,403.90 crore in the corresponding period of the previous fiscal year. During the quarter ended March 31, 2021, the sale of cement for the company is 3.21 million tonne, compared to 2.93 million tonne in the corresponding period of the previous year with a growth of 10 per cent, the company said in a post earning statement.

ICRA pegs India's Q4 GDP growth at 2%; FY21 at 8.45%

Total expenses were at Rs 1,296.05 crore in the quarter as against Rs 1,218.69 crore in March quarter of 2019-20. For the fiscal year ended March 31, 2021, The Ramco Cements' net profit was up 29.63 per cent at Rs 784.33 crore. It was Rs 605.07 crore in the previous year.

However, total revenue was down to Rs 5,321.37 crore in 2020-21. It was Rs 5,422.80 crore in 2019-20. During FY2020-21, southern markets have de-grown due to COVID-19, prolonged monsoon whereas in the eastern markets volumes have grown, it said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

The Ramco Cements Q4 profit up 51% to Rs 216 crore

Total revenue was up 16.93 per cent to Rs 1,641.53 crore during the quarter under review as against Rs 1,403.90 crore in the corresponding period of the previous fiscal year.

Representative image.

Related stories